Karuna Therapeutics updated its IPO filing to include a new maximum of $85 million+. The company will offer 4,375,000 shares. The company plans to trade on NASDAQ... read more
Karuna Therapeutics updated its IPO filing to include a new maximum of $85 million+. The company will offer 4,375,000 shares. The company plans to trade on NASDAQ... read more
Change Healthcare, which provides healthcare revenue cycle management software and services, announced terms for its IPO and equity offering on 6/14/19. The company will raise up to $900 million+... read more
Seres Therapeutics, Inc. (Nasdaq: MCRB) (“Seres”), a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring... read more
Dermavant updated its filing on 6/10/19 and will issue 7,700,000 shares and raise up to $123.9 million. Roivant is the controlling shareholder and will have the right to appoint two directors to... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,